ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

December 15, 2000

Mark Israel To Direct Norris Cotton Center

October 19, 2001

In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas

January 1, 1993

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009